NASDAQ NMS - GLOBAL MARKET · GPCR
+5.30% · +$2.44 · Vol 915.2K
Market closed · last close 4:00 PM ET · price as of 16:35:33 ET
Structure Therapeutics Inc

Structure Therapeutics Inc

Pharmaceuticals
$48.47
Card
Relationship Map

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

Score not reportedVeridion does not publish a score-history trend for GPCR until the ticker has a real scored snapshot. No trend is implied for this page.Review methodology
NO SCORE SNAPSHOT COVERAGE
AI Analysis
Sovereign

Why is GPCR moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for GPCR are being assembled.
About Structure Therapeutics Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2023
Employees
233
Country
US

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$45.65
Day high
$49.65
Day low
$44.80
Previous close
$46.03
52W high
$93.79
-48.32% from high
52W low
$16.20
42% of range
Market cap
$3.3B
EPS
$-1.3500
Beta
1.17
Shares out
71.1M
Volume
915.2K
1.06× rel vol
Avg volume
863.6K
VWAP
$48.28
Price history computed in-house
1W
-9.16%
1M
+8.90%
3M
-4.49%
1Y
+151.79%
YTD
-30.31%
SMA 50 $43.98 · above
SMA 200 $50.93 · below
52W position 42%
Veridion warehouse edge

Warehouse intelligence for GPCR.

Veridion Score
Not reported
Six-factor detail requires Sovereign.
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Related public evidence

Continue the GPCR research trail.

Relationship mapTrace receipt-backed holders and filings around GPCR.Congress disclosuresOpen receipt and filing context for GPCR.MethodologyReview score inputs, coverage rules, and limitations.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

Receipt-backed filing rows for GPCR are being assembled from the latest scheduled snapshot.

Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

GPCR contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for GPCR in this window.
Lobbying spend

GPCR lobbying filings, year to date.

Registered lobbying filings matched to Structure Therapeutics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for GPCR in this window.
Latest news · GPCR
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for GPCR.
Options
Sovereign unlock shows live options positioning for GPCR.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.